Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment
Authors:
- R L LalondeRLR L Lalonde
- J A WagnerJWJ A Wagner
- 23 September 2009
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 86 (5) , 557-561
Abstract
Severe renal impairment can, through diverse mechanisms, alter the pharmacokinetics (PK) of drugs that are renally eliminated and even of some drugs that are nonrenally eliminated. Consequently, dose adjustment for new molecular entities in patients with renal insufficiency is a critical issue in drug development. Clinical pharmacology studies undertaken in patients with renal impairment are generally quite small. We therefore recommend that all pertinent pharmacokinetic data relating to subjects with different degrees of renal impairment and from different clinical trials, including population pharmacokinetic evaluation, form the basis for dosage recommendations in renal impairment. The Modification of Diet in Renal Disease (MDRD) equation has gained popularity for renal insufficiency classification, but traditional equations such as the Cockcroft-Gault (C-G) formula should enjoy continued use so as to avoid confusion, particularly for drugs for which dosing guidelines have previously been developed.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing Kidney Function: Cockcroft‐Gault and Modification of Diet in Renal DiseasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and TransportClinical Pharmacology & Therapeutics, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Comparison of the Modification of Diet in Renal Disease and Cockcroft–Gault Equations for Antimicrobial Dosage AdjustmentsAnnals of Pharmacotherapy, 2006
- Assessing Kidney Function — Measured and Estimated Glomerular Filtration RateNew England Journal of Medicine, 2006
- Creatinine Clearance versus Glomerular Filtration Rate for the Use of Renal Drug Dosing in Patients with Kidney DysfunctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Problems with the Use of the Modified Diet in Renal Disease Formula to Estimate Renal FunctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal ImpairmentThe Journal of Clinical Pharmacology, 2004
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6Cytogenetic and Genome Research, 1976